Drug Topics e-News:
Having trouble viewing this email? View in a browser.
|
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.
|
to Drug Topics e-News
|
|
|
|
 |
 |
| Newest: Diabetic peripheral neuropathy |
| For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here |
|
|
|
Survey
This month we would like to know...
AMA is seeking repeal of the PPACA reimbursement rule that requires prescriptions for OTCs. Do you agree with AMA?
|
|
|
Pharmacy benefit managers should be required to be more transparent in health insurance exchanges, the National Community Pharmacists Association asserted in comments recently submitted to the U.S. Office of Personnel Management.
Read full article. |
 |
|
|
 |
A discussion generated by
Drug Topics’ readers, editorial staff, and advisory board
Diana Jurss is a practicing pharmacist
in western North Carolina. |
With prescription drug abuse of controlled substances, especially narcotics, now epidemic
in our country, where does our responsibility lie? Read full article.
|
Dr. Anne Schuchat, assistant surgeon general of the United States, recently recognized the National Association of Chain Drug Stores and other organizations for their participation in the annual National Influenza Vaccine Summit.
Read full article. |
|
Gary Pelletier, director and team leader for Pfizer Helpful Answers, was recently appointed the Chairman of the Board of Managers of the Together Rx Access program. The Together Rx Access card was created by several leading pharmaceutical manufacturers to help working Americans and their families gain access to savings on prescriptions at their community pharmacies.
Read full article. |
|
|
Retail pharmacy groups criticized a new study suggesting that adherence to oral antidiabetic medications improves when patients use mail-order pharmacies. Read full article.
|
|
FDA has announced changes to the boxed warnings, contraindications, and warnings sections of the labels
for 32 products. Read full article.
|
|
FDA has approved emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Complera, Gilead Sciences), a complete single-tablet regimen for the treatment of HIV-1 infection in treatment-naive adults. Read full article.
|
Career Opportunities
|
Meetings and Events
August 27-30, 2011 NACDS Pharmacy & Technology Conference
Boston
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678
September 26-27, 2011 2nd Annual Pharmaceutical Labeling Summit
Washington, D.C.
Contact:
Jeff Grizzel, Conference Director
FDA News
300 N. Washington St., #200
Falls Church, VA 22046-3431
703-538-7668
jgrizzel@fdanews.com
www.fdanews.com/PharmaLabeling
October 6-7, 2011 NCPA Diabetes Accreditation
Standards-Practical Applications (DASPA)
Nashville, TN
Contact:
100 Daingerfield Road
Alexandria, VA 22314
800-544-7447
October 8-12 2011 NCPA Annual Convention
Nashville, TN
Contact:
100 Daingerfield Road
Alexandria, VA 22314
800-544-7447
November 29, 2011 NACDS Foundation 13th Annual Dinner
New York, NY
Contact:
Jennifer Sargeant, Manager, Foundation Programs and Education, NACDS
703-837-4224
|
|
|
|
| Contact Us |
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here |
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
